Innate and adaptive mechanisms to control of pathological intestinal inflammation

被引：58

作者：

Kelsall, B. L. ^{[1
]}

机构：

[1] NIAID, Mucosal Immunobiol Sect, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA

来源：

JOURNAL OF PATHOLOGY | 2008年 / 214卷 / 02期

关键词：

intestine; inflammation; Crohn's disease; ulcerative colitis; dendritic cells; epithelium; bacteria;

D O I：

10.1002/path.2286

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The intestine is the home of a tremendous number of commensal organisms that have a primary role in host metabolism. As a consquence, the gut mucosa has evolved multiple layers of protection. This review highlights both innate and adaptive mechanisms that prevent bacterial invasion and abnormal intestinal inflamamation, bow a failure of these mechanisms may be involved in the pathogenesis of inflammatory bowel diseases, and discusses new findings implicating dendritic cells as central to the induction of active mucosal tolerance to commensal bacteria. Copyright (C) 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

引用

页码：242 / 259

页数：18

共 214 条

[51] Inflammatory bowel disease: Etiology and pathogenesis [J].

Fiocchi, C .

GASTROENTEROLOGY, 1998, 115 (01) :182-205

[52] Nod-like proteins in immunity, inflammation and disease [J].

Fritz, Jorg H. ;

Ferrero, Richard L. ;

Philpott, Dana J. ;

Girardin, Stephen E. .

NATURE IMMUNOLOGY, 2006, 7 (12) :1250-1257

[53] Increased expression of interleukin 17 in inflammatory bowel disease [J].

Fujino, S ;

Andoh, A ;

Bamba, S ;

Ogawa, A ;

Hata, K ;

Araki, Y ;

Bamba, T ;

Fujiyama, Y .

GUT, 2003, 52 (01) :65-70

[54] Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody [J].

Fuss, IJ ;

Becker, C ;

Yang, ZQ ;

Groden, C ;

Hornung, RL ;

Heller, F ;

Neurath, MF ;

Strober, W ;

Mannon, PJ .

INFLAMMATORY BOWEL DISEASES, 2006, 12 (01) :9-15

[55] Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn's disease [J].

Gewirtz, AT ;

Vijay-Kumar, M ;

Brant, SR ;

Duerr, RH ;

Nicolae, DL ;

Cho, JH .

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2006, 290 (06) :G1157-G1163

[56] Reinforcing the mucus: a new therapeutic approach for ulcerative colitis? [J].

Gibson, PR ;

Muir, JG .

GUT, 2005, 54 (07) :900-903

[57] Metagenomic analysis of the human distal gut microbiome [J].

Gill, Steven R. ;

Pop, Mihai ;

DeBoy, Robert T. ;

Eckburg, Paul B. ;

Turnbaugh, Peter J. ;

Samuel, Buck S. ;

Gordon, Jeffrey I. ;

Relman, David A. ;

Fraser-Liggett, Claire M. ;

Nelson, Karen E. .

SCIENCE, 2006, 312 (5778) :1355-1359

[58] Epithelial barrier defects in ulcerative colitis: Characterization and quantification by electrophysiological imaging [J].

Gitter, AH ;

Wullstein, F ;

Fromm, M ;

Schulzke, JD .

GASTROENTEROLOGY, 2001, 121 (06) :1320-1328

[59] Tight junction proteins [J].

González-Mariscal, L ;

Betanzos, A ;

Nava, P ;

Jaramillo, BE .

PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2003, 81 (01) :1-44

[60] Molecular pathogenesis of inflammatory bowel disease:: Genotypes, phenotypes and personalized medicine [J].

Goyette, Philippe ;

Labbe, Catherine ;

Trinh, Truc T. ;

Xavier, Ramnik J. ;

Rioux, John D. .

ANNALS OF MEDICINE, 2007, 39 (03) :177-199

← 1 2 3 4 5 6 7 8 9 10 →